Effects of GnRH agonist for luteal phase support

Effects of GnRH agonist for luteal phase support in assisted reproductive cycles

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110509006420N20

Enrollment

200

Registered

2020-03-11

Start date

2020-01-01

Completion date

Unknown

Last updated

2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female infertility. Female infertility

Interventions

Intervention 1: taking 0/1 mg triptorelin in 0-3-6 days after fresh emeryo transfer plus 400mg vaginal cyclogest twice daily for luteal phase support. Intervention 2: Control group: taking 400mg vagi

Eligibility

Sex/Gender

Female

Age

20 Years to 39 Years

Inclusion criteria

Inclusion criteria: age 20-39 years fresh embryo transfer cycles HCG -triggered cycles

Exclusion criteria

Exclusion criteria: Absence of good quality embryo Ovarian hyper stimulation (more than 18 mature follicles with size more than 14 mm during ovarian stimulation) or estradiol level in trigger days more than 4000 pmol/l Severe male factor

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: serum BHCG.;Clinical pregnancy. Timepoint: 6 weeks after embryo transfer. Method of measurement: sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Eftekhar

Yazd University of Medical Sciences

eftekhar@ssu.ac.ir+98 35182470856

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026